CY1946A - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
CY1946A
CY1946A CY194692A CY194692A CY1946A CY 1946 A CY1946 A CY 1946A CY 194692 A CY194692 A CY 194692A CY 194692 A CY194692 A CY 194692A CY 1946 A CY1946 A CY 1946A
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
tablet containing
dirithromycin form
Prior art date
Application number
CY194692A
Other languages
English (en)
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY1946A publication Critical patent/CY1946A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CY194692A 1991-04-29 1992-04-27 Pharmaceutical compounds CY1946A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
CY1946A true CY1946A (en) 1992-04-27

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
CY194692A CY1946A (en) 1991-04-29 1992-04-27 Pharmaceutical compounds
CY197597A CY1975A (en) 1991-04-29 1997-09-05 Pharmaceutical formulation containing dirithromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY197597A CY1975A (en) 1991-04-29 1997-09-05 Pharmaceutical formulation containing dirithromycin

Country Status (27)

Country Link
EP (2) EP0511800B1 (sv)
JP (2) JP3333545B2 (sv)
KR (2) KR100194307B1 (sv)
CN (2) CN1030611C (sv)
AT (2) ATE138924T1 (sv)
AU (2) AU646734B2 (sv)
BR (2) BR9201541A (sv)
CA (2) CA2067275C (sv)
CY (2) CY1946A (sv)
CZ (2) CZ282021B6 (sv)
DE (2) DE69211220T2 (sv)
DK (2) DK0511800T3 (sv)
ES (2) ES2093779T3 (sv)
FI (2) FI101795B1 (sv)
GR (2) GR3020439T3 (sv)
HK (2) HK153696A (sv)
HU (2) HU213613B (sv)
IE (2) IE74885B1 (sv)
IL (2) IL101705A (sv)
MX (2) MX9201946A (sv)
MY (2) MY109498A (sv)
NO (2) NO179504C (sv)
NZ (2) NZ242505A (sv)
RU (2) RU2070203C1 (sv)
TW (2) TW216399B (sv)
YU (2) YU44392A (sv)
ZA (2) ZA922777B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (sv) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
DK0915899T3 (da) * 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
CN1230883A (zh) * 1996-09-24 1999-10-06 伊莱利利公司 包衣颗粒制剂
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
EP2104680B1 (en) * 2006-12-05 2013-01-09 Bristol-Myers Squibb Company Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MY114226A (en) 2002-09-30
FI921877A (fi) 1992-10-30
DK0511800T3 (da) 1997-04-21
IL101704A (en) 1998-02-22
EP0511800B1 (en) 1996-10-23
CA2067275C (en) 2002-11-26
HU9203168D0 (en) 1992-12-28
JP3333545B2 (ja) 2002-10-15
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
AU1525592A (en) 1992-11-05
GR3021706T3 (en) 1997-02-28
BR9201541A (pt) 1992-12-01
HU215917B (hu) 1999-03-29
FI101795B (sv) 1998-08-31
NO180450C (no) 1997-04-23
CA2067274A1 (en) 1992-10-30
HUT62595A (en) 1993-05-28
CN1066186A (zh) 1992-11-18
NO921616D0 (no) 1992-04-27
DK0511799T3 (da) 1996-06-24
JPH05117154A (ja) 1993-05-14
DE69214710D1 (de) 1996-11-28
JPH05117289A (ja) 1993-05-14
GR3020439T3 (en) 1996-10-31
HU213613B (en) 1997-08-28
ATE144425T1 (de) 1996-11-15
KR100193742B1 (ko) 1999-06-15
CZ282218B6 (cs) 1997-06-11
NO179504B (no) 1996-07-15
MX9201946A (es) 1992-11-01
CN1069197C (zh) 2001-08-08
CS127792A3 (en) 1992-11-18
KR920019364A (ko) 1992-11-19
CA2067274C (en) 2002-10-15
NO180450B (no) 1997-01-13
IE921346A1 (en) 1992-11-04
IL101705A (en) 1996-01-31
DE69211220D1 (de) 1996-07-11
YU44492A (sh) 1994-06-24
FI921876A0 (fi) 1992-04-27
EP0511799B1 (en) 1996-06-05
IE74885B1 (en) 1997-08-13
NZ242505A (en) 1993-06-25
ZA922777B (en) 1993-10-15
AU655978B2 (en) 1995-01-19
JP3135672B2 (ja) 2001-02-19
NO179504C (no) 1996-10-23
KR100194307B1 (ko) 1999-06-15
CY1975A (en) 1997-09-05
KR920019365A (ko) 1992-11-19
ATE138924T1 (de) 1996-06-15
TW315371B (sv) 1997-09-11
CS127692A3 (en) 1992-11-18
ES2088098T3 (es) 1996-08-01
IL101704A0 (en) 1992-12-30
NO921616L (no) 1992-10-30
IE921345A1 (en) 1992-11-04
HU9201398D0 (en) 1992-07-28
AU646734B2 (en) 1994-03-03
NO921617L (no) 1992-10-30
NO921617D0 (no) 1992-04-27
YU44392A (sh) 1994-12-28
HUT63956A (en) 1993-11-29
FI101795B1 (sv) 1998-08-31
MX9201944A (es) 1992-11-01
HK153696A (en) 1996-08-16
IE76296B1 (en) 1997-10-08
HK215096A (en) 1996-12-13
TW216399B (sv) 1993-11-21
DE69211220T2 (de) 1996-11-07
FI921876A (fi) 1992-10-30
DE69214710T2 (de) 1997-03-13
BR9201540A (pt) 1992-12-01
NZ242506A (en) 1993-09-27
ES2093779T3 (es) 1997-01-01
RU2045953C1 (ru) 1995-10-20
MY109498A (en) 1997-02-28
FI921877A0 (fi) 1992-04-27
EP0511799A1 (en) 1992-11-04
RU2070203C1 (ru) 1996-12-10
EP0511800A1 (en) 1992-11-04
IL101705A0 (en) 1992-12-30
ZA922776B (en) 1993-10-15
AU1525792A (en) 1992-11-05
CN1030611C (zh) 1996-01-03
CA2067275A1 (en) 1992-10-30

Similar Documents

Publication Publication Date Title
GB2269382B (en) Pharmaceutical compounds
GR3020439T3 (en) Pharmaceutical compounds
ZA927717B (en) Pharmaceutical compounds
GB9107754D0 (en) Pharmaceutical compounds
GB9107755D0 (en) Pharmaceutical compounds
GB9108742D0 (en) Pharmaceutical compounds
GB9116593D0 (en) Pharmaceutical compounds
GB9124439D0 (en) Pharmaceutical compounds
GB9127442D0 (en) Pharmaceutical compounds
GB9107486D0 (en) Pharmaceutical compounds
ZA929825B (en) A pharmaceutical formulation.